Retatrutide

Price range: $125.00 through $1,500.00

Retatrutide is an experimental peptide being studied as a triple-receptor agonist, meaning it activates three hormone receptors — GLP-1, GIP, and glucagon. Researchers are investigating how this combined activity may affect metabolism, appetite control, energy balance, and blood sugar regulation. Early and ongoing studies have looked at its effects on body weight, insulin response, and liver fat, and scientists continue to compare it with other GLP-1–based research compounds. For research use only. Not intended for human consumption or for medical, diagnostic, or therapeutic purposes. Products may ship as 20 mg and 30 mg units if 50 mg stock is unavailable.

SKU: VP-RETA Categories: ,

PRODUCT FAQ

What is Retatrutide being studied for in research?
Retatrutide is studied in metabolic research for its activity as a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways related to appetite, energy balance, and glucose regulation.
How is Retatrutide different from GLP-1–only compounds?
Unlike GLP-1–only compounds, Retatrutide activates three hormone receptors, allowing researchers to study broader metabolic signaling effects in preclinical and clinical models.
Which metabolic pathways are examined with Retatrutide?
Research focuses on pathways tied to insulin signaling, appetite control, energy expenditure, and body weight regulation.
Is Retatrutide considered experimental?
Yes. Retatrutide remains an investigational peptide under active research and is not approved for general use.
What makes triple-agonist peptides important in research?
Triple-agonists allow scientists to observe how multiple hormone systems interact at once, which may reveal new metabolic regulation mechanisms.